Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Juveena Hydrogel System Pivotal Study

Safety and Effectiveness of Juveena™ Hydrogel System Following Transcervical Gynecologic Procedures (TCGP) At High-Risk for Intrauterine Adhesions: A Multicenter Randomized Controlled Subject and Evaluator Blinded Pivotal Study

female physician talking with female patient
AGE: 18+ years old
GENDER: Female
TYPE: Interventional Treatment
CONDITION: Surgery for fibroids, Asherman Syndrome
LOCATION: University Hospitals Medical Centers

Learn More About This Research Study

For more information, please contact study coordinator, Bridget Ermlich, at 216-844-8091 or by completing the form below.

Study Purpose

The purpose of this study is to evaluate whether filling the uterus with a soft gel-like material (“Juveena Hydrogel”) at the end of your gynecological surgical procedure can safely and effectively reduce the development of adhesions. The gel dissolves and will not need to be removed at another time.

Who Can Participate

Premenopausal women 18 years of age or older with a hysteroscopic diagnosis of moderate to severe intrauterine adhesions (Asherman Syndrome), or patients undergoing surgery for fibroids may be eligible for this study.

I'm not a robot

  • STUDY ID# 20222824